Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Inspira Technologies Oxy BHN ( (IINN) ) has provided an update.
On June 20, 2025, Inspira Technologies Oxy B.H.N. Ltd. held an Extraordinary General Meeting of Shareholders where a quorum was present, and the shareholders approved the agenda item outlined in the company’s notice and proxy statement. This approval is significant as it aligns with the company’s strategic objectives and is incorporated into their ongoing registration statements with the SEC, potentially impacting their market positioning and shareholder value.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. operates in the medical technology industry, focusing on developing innovative respiratory support technologies. The company is known for its advanced systems aimed at improving patient care and outcomes in respiratory therapy.
Average Trading Volume: 514,558
Technical Sentiment Signal: Hold
Current Market Cap: $18.77M
For detailed information about IINN stock, go to TipRanks’ Stock Analysis page.